Amgen to deploy Veeva Vault CRM globally to speed delivery of new therapies.

Amgen has announced plans to implement Veeva Vault CRM worldwide, enhancing its long-term collaboration with Veeva Systems. This move aims to accelerate the development and delivery of innovative medicines to patients globally by improving speed and agility in commercial operations. Veeva Vault CRM, part of the Vault CRM Suite, offers advanced tools to engage healthcare professionals and uncover treatment barriers, supporting Amgen's goal to launch new therapies effectively. This deployment underscores Amgen's commitment to leveraging technology to improve patient outcomes and address challenging diseases.

Shares of Veeva Systems (VEEV) are trading at USD 263.00, down 1.01% on the day, while Amgen (AMGN) is priced at USD 380.42, down 0.28%. Veeva's market cap stands at $43.01 billion and Amgen's at $206.25 billion as of Sep 15, 2026 18:13 WIB. This data shows the current market valuation of both companies involved in the new global CRM collaboration.